Recombinant Zika Virus VLP
Specification
Related Products
| Cat#: |
ZIK-639 |
| Product Name: |
Recombinant Zika Virus VLP |
| Description: |
Zika Virus VLP (Virus-Like Particle) is a unique product that has been developed in response to the need for high purity, properly assembled and glycosylated Zika virus antigens for use in the development of Zika virus diagnostics and in vaccine development and research/development (including use as an immunogen). Like its related product, Zika Virus NS1, the Zika Virus VLP is produced in human cell lines using state-of-the-art expression techniques. In contrast to our Dengue serotype 1-4 VLPs, Zika Virus VLP has been constructed purely from Zika virus sequences. Concentration and purification is then performed by a series of ultracentrifuge and chromatographical methods which result in VLPs of exceptional quality and purity. |
| Gene: |
VLP |
| Species: |
Zika Virus |
| Source: |
HEK293 |
| Synonyms: |
Zika Virus VLP |
| Formulation: |
DPBS pH 7.4 |
| Concentration: |
0.21 mg/mL |
| Purity: |
Greater than 95% purity |
| Storage: |
Short term: Short-term storage above-80 centigrade is not recommended. If necessary snap-freeze in liquid nitrogen for -80 centigrade storage. Long Term:-80 centigrade |
| Freezing: |
Multiple freeze/thaw cycles are to be avoided. If necessary snap-freeze in liquid nitrogen. |
| Sequence Strain: |
Suriname Z1106033 |
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
